Lifen Cao

444 total citations
38 papers, 327 citations indexed

About

Lifen Cao is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lifen Cao has authored 38 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 15 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lifen Cao's work include Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Lifen Cao is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Lifen Cao collaborates with scholars based in United States, Brazil and China. Lifen Cao's co-authors include Alberto J. Montero, Nickolas Stabellini, Megan E. Miller, Kristin Waite, Jill S. Barnholtz‐Sloan, John Shanahan, Robert Shenk, David A. Boothman, Haining Cui and Xiaoyu Liu and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lifen Cao

37 papers receiving 322 citations

Peers

Lifen Cao
Malini Gupta United States
Surbhi Agrawal United States
K Clagett-Carr United States
F. H. Hausheer United States
Malini Gupta United States
Lifen Cao
Citations per year, relative to Lifen Cao Lifen Cao (= 1×) peers Malini Gupta

Countries citing papers authored by Lifen Cao

Since Specialization
Citations

This map shows the geographic impact of Lifen Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifen Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifen Cao more than expected).

Fields of papers citing papers by Lifen Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifen Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifen Cao. The network helps show where Lifen Cao may publish in the future.

Co-authorship network of co-authors of Lifen Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Lifen Cao. A scholar is included among the top collaborators of Lifen Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifen Cao. Lifen Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stabellini, Nickolas, Lifen Cao, Christopher W. Towe, Amanda L. Amin, & Alberto J. Montero. (2023). Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A National Cancer Database analysis. Cancer Medicine. 12(19). 19607–19616. 1 indexed citations
2.
Stabellini, Nickolas, Jennifer Cullen, Márcio Sommer Bittencourt, et al.. (2023). Allostatic load and cardiovascular outcomes in males with prostate cancer. JNCI Cancer Spectrum. 7(2). 19 indexed citations
3.
Stabellini, Nickolas, Lifen Cao, Christopher W. Towe, et al.. (2023). Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer. Journal of the National Comprehensive Cancer Network. 21(10). 1011–1019.e6. 3 indexed citations
4.
Stabellini, Nickolas, Lifen Cao, Christopher W. Towe, et al.. (2023). Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis. Frontiers in Oncology. 13. 1115208–1115208. 3 indexed citations
5.
Stabellini, Nickolas, Jennifer Cullen, Lifen Cao, et al.. (2023). Racial disparities in breast cancer treatment patterns and treatment related adverse events. Scientific Reports. 13(1). 1233–1233. 23 indexed citations
6.
Sarode, Anuja L., Lifen Cao, Robert R. Shenk, et al.. (2022). Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysis. Surgery. 172(3). 821–830. 3 indexed citations
7.
Cao, Lifen, Philip A. Linden, Tithi Biswas, et al.. (2022). Modeling the COVID Pandemic: Do Delays in Surgery Justify Using Stereotactic Radiation to Treat Low-Risk Early Stage Non–Small Cell Lung Cancer?. Journal of Surgical Research. 283. 532–539. 3 indexed citations
8.
Cao, Lifen, et al.. (2022). Trends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer Database. The American Journal of Surgery. 225(1). 75–83. 6 indexed citations
9.
Stabellini, Nickolas, Jennifer Cullen, Justin X. Moore, et al.. (2022). Abstract 10355: Allostatic Load and Cardiovascular Outcomes in Males With Prostate Cancer. Circulation. 146(Suppl_1). 1 indexed citations
11.
Cao, Lifen, Robert Shenk, Nickolas Stabellini, et al.. (2021). Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis. Breast Cancer Research and Treatment. 191(1). 169–176. 3 indexed citations
12.
Walsh, Kenneth, David O’Connor, Fred A. Weaver, et al.. (2020). Survival after endovascular therapy in patients with ruptured thoracic aortic diseases: Results from the Global Registry for Endovascular Aortic Treatment Registry. Journal of Vascular Surgery. 72(5). 1544–1551. 5 indexed citations
13.
Cao, Lifen, et al.. (2020). Arterial Thrombosis in an Ambulatory COVID-19 Patient in Recovery. Zenodo (CERN European Organization for Nuclear Research). 5(5). 3 indexed citations
14.
O’Connor, David, et al.. (2020). Creation of a dedicated line service in the New Jersey epicenter of COVID-19. Journal of Vascular Surgery. 72(4). 1159–1160. 1 indexed citations
15.
Cao, Lifen. (2014). Effect of nebulization gas flow on determination of potassium,sodium,calcium,magnesium,aluminum,iron and titanium in potash feldspar by ICP-AES. Metallurgical Analysis. 1 indexed citations
16.
Cao, Lifen, Long Shan Li, Ling Xiao, et al.. (2014). Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers. Antioxidants and Redox Signaling. 21(2). 237–250. 32 indexed citations
17.
Bey, Erik A., Kathryn E. Reinicke, Melissa C. Srougi, et al.. (2013). Catalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers. Molecular Cancer Therapeutics. 12(10). 2110–2120. 84 indexed citations
18.
Cao, Lifen. (2013). Application of Fingerprint Technique in Tea Research. Chaye kexue. 1 indexed citations
20.
Cao, Lifen. (2011). Determination of Sixteen Food Additives in Preserved Fruits by High Performance Liquid Chromatography. Journal of Instrumental Analysis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026